Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
General Information
ATP Inserted / Updated: CLP00/ATP15 ![]() CLP Classification (Table 3)
|
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Seveso Data | |
---|---|
Seveso Substance | Seveso Categories |
Да |
P8
|
ATP Inserted / Updated: ATP15 ![]() CLP Classification (Table 3)
|
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Seveso Data | |
---|---|
Seveso Substance | Seveso Categories |
Не |
Notified classification and labelling
General Information
EC / List no.
![]() |
Name |
CAS Number
![]() |
---|---|---|
231-714-2 | Nitric acid | 7697-37-2 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 70 % ≤ C ≤ 99 % |
Note B
|
State/Form
|
170 | ![]() |
View details | |
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
Note B
|
State/Form
|
85 | ![]() |
View details | |
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 (ATE = 2.65 mg/L...) | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Note B
|
State/Form
|
2022 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
State/Form
|
702 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
State/Form
|
462 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % |
State/Form
|
87 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % |
Note B
|
State/Form
|
62 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
State/Form
|
60 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 GHS06 Dgr |
State/Form
|
60 | View details | |||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
State/Form
|
59 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Irrit. 2; : 1 % < C < 5 % |
Note B
|
State/Form
|
55 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
H271 |
Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
39 | View details | |||||||
H314 | |||||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Irrit. 2; : 1 % ≤ C < 5 % Skin Corr. 1B; : 5 % ≤ C < 20 % Eye Dam. 1; : C ≥ 3 % Skin Corr. 1A; : C ≥ 20 % Eye Irrit. 2; : 1 % ≤ C < 3 % |
36 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Eye Dam. 1; : C ≥ 3 % Ox. Liq. 3; : C ≥ 65 % Eye Irrit. 2; : 1 % ≤ C < 3 % Ox. Liq. 3; : 70 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Irrit. 2; : 1 % ≤ C < 5 % |
31 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
State/Form
|
29 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Met. Corr. 1; : C ≥ 20 % |
Note B
|
State/Form
|
26 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % |
State/Form
|
23 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Eye Irrit. 2; : 1 % ≤ C < 3 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Irrit. 2; : 1 % ≤ C < 5 % Ox. Liq. 3; : C ≥ 65 % Eye Dam. 1; : C ≥ 3 % |
22 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
State/Form
|
18 | View details | |||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % |
Note B
|
State/Form
|
16 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
13 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % |
Note B
|
13 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Skin Corr. 1B | H314 | H314 |
GHS05 Dgr |
State/Form
|
12 | View details | |||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
11 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 2 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
State/Form
|
7 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 2 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS08 GHS05 Dgr |
6 | View details | ||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
STOT SE 1 | H370 (other:Respirato...) (inhalation) | H370 (I) | |||||||||
STOT SE 1 | H370 (Respiratory tra...) (inhalation) | H370 (I) | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
Note B
|
![]() |
State/Form
|
6 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 (H272) |
GHS03 GHS05 Dgr |
Note B
|
5 | View details | |||||
Skin Corr. 1A | H314 | H314 (H314) | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
State/Form
|
5 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % Met. Corr. 1; : C ≥ 5 % |
Note B
|
State/Form
|
4 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : C ≥ 5 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
Note B
|
State/Form
|
4 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
State/Form
|
4 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Skin Irrit. 2; : C < 3 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Eye Dam. 1; : C ≥ 3 % Eye Irrit. 2; : C < 3 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % |
Note B
|
State/Form
|
3 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Skin Corr. 1A | H314 | H314 |
GHS05 Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : C ≥ 5 % |
Note B
|
State/Form
|
2 | View details | |||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
State/Form
|
2 | View details | |||
H290 | |||||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Met. Corr. 1; : C ≥ .2 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % |
Note B
|
State/Form
|
2 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Eye Irrit. 2; : 1 % < C < 3 % Ox. Liq. 2; : C ≥ 99 % Eye Dam. 1; : C ≥ 3 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Irrit. 2; : 1 % < C < 5 % |
Note B
|
2 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Met. Corr. 1 | H290 | H290 | EUH071 |
GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
State/Form
|
2 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
2 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
Note B
|
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | ||||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Not Classified | 1 | ||||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % |
Note B
Note 2 Note 1 |
State/Form
|
1 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | ||||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Sol. 2 | H272 | H272 |
GHS03 GHS07 GHS05 GHS09 GHS06 Dgr |
1 | View details | ||||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
H335 | |||||||||||
Acute Tox. 1 | H330 | H330 |
GHS06 Dgr |
State/Form
|
1 | View details | |||||
Ox. Liq. 1 | H271 | H271 |
GHS03 Dgr |
State/Form
|
1 | View details | |||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 100 % Skin Corr. 1A; : 20 % ≤ C < 100 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Met. Corr. 1 | H290 | H290 |
GHS08 GHS05 GHS06 Dgr |
State/Form
|
1 | View details | |||||
Asp. Tox. 1 | H304 | H304 | |||||||||
Skin Corr. 1B | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 2 | H330 | H330 | |||||||||
STOT SE 1 | H370 (Respiratory Sys...) | H370 | |||||||||
STOT SE 1 | H370 (other:Respirato...) | H370 | |||||||||
STOT RE 1 | H372 (Respiratory Sys...) | H372 | |||||||||
STOT RE 1 | H372 (other:Respirato...) | H372 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C ≤ 20 % |
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C > 20 % |
Note B
|
State/Form
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 |
GHS07 GHS05 Dgr |
State/Form
|
1 | View details | |||||
Skin Corr. 1A | H314 | H314 | |||||||||
H272 (H314) |
GHS03 GHS05 Dgr |
State/Form
|
1 | View details | |||||||
Ox. Liq. 2 | H272 | H272 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
State/Form
|
1 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Skin Corr. 1A | H314 | H314 |
GHS05 Dgr |
State/Form
|
1 | View details | |||||
Ox. Liq. 2 | H272 | H272 |
GHS03 GHS05 Dgr |
State/Form
|
1 | View details | |||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
1 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS07 GHS05 Dgr |
Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % |
State/Form
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
H315 | |||||||||||
H319 | |||||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % |
1 | View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % |
Note B
|
State/Form
|
1 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 2; : C ≥ 70 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 70 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Aquatic Chronic 3 | H412 | H412 | |||||||||
Met. Corr. 1 | H290 | H290 | EUH071 |
GHS05 GHS06 Dgr |
Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
State/Form
|
1 | View details | ||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 1 | H330 | H330 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C ≤ 100 % Skin Corr. 1A; : 20 % ≤ C ≤ 100 % |
1 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 Dgr |
Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
State/Form
|
1 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 100 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Ox. Liq. 3; : 65 % ≤ C < 100 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
Note B
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1B | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 2 | H272 | H272 |
GHS03 GHS05 GHS06 Dgr |
Note B
|
1 | View details | |||||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % |
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
Acute Tox. 3 | H331 | H331 | |||||||||
Ox. Liq. 3 | H272 | H272 | EUH071 |
GHS03 GHS05 GHS06 Dgr |
Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % |
State/Form
|
1 | View details | |||
Skin Corr. 1 | H314 | H314 | |||||||||
Acute Tox. 3 | H331 | H331 |
Number of Aggregated Notifications: 71